Skip to main content
Equibles

FMR LLC

Position in PGEN — Precigen, Inc.

CIK 315066 BOSTON, MA
Back to PGEN Full portfolio

Position in PGEN

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$14,650,043
+$6,915,477 QoQ
Shares Held
2,570,183
+28.6% QoQ
Ownership
0.718%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#13
of 210 holders
Holding Since
Jun 2020
22 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in PGEN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

FMR LLC holds $61,908,415,112 across 370 Biotechnology names. PGEN ranks #152 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARGX
Argenx SE
 5,231,452 $4,853,584,218
2 ALNY
Alnylam Pharmaceuticals, Inc.
 15,023,962 $4,522,663,276
3 MRNA
Moderna, Inc.
 51,859,891 $3,631,748,165
4 ROIV
Roivant Sciences Ltd.
 81,020,390 $2,867,311,601
5 RVMD
Revolution Medicines, Inc.
 12,200,422 $2,284,895,029
6 IONS
Ionis Pharmaceuticals Inc
 24,631,956 $1,953,067,789
7 INSM
INSMED Inc
 16,143,583 $1,721,228,815
8 KRYS
Krystal Biotech, Inc.
 4,418,197 $1,642,111,277

All Filings in PGEN

Export CSV
22 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $14,650,043 2,570,183
2026-03-31 $7,734,566 1,998,596
2025-12-31 $19,446,107 4,652,179
2025-09-30 $383,817 116,662
2025-06-30 $474,622 334,241
2025-03-31 $472,539 317,141
2024-12-31 $423,989 378,563
2024-09-30 $327,943 345,204
2024-06-30 $431,610 273,171
2024-03-31 $370,670 255,635
2023-12-31 $342,927 255,916
2023-09-30 $444,977 313,365
2023-06-30 $231,725 201,501
2023-03-31 $211,350 199,388
2022-12-31 $303,044 199,372
2022-09-30 $426,882 201,360
2022-06-30 $266,172 198,636
2022-03-31 $425,812 201,807
2021-12-31 $7,093 1,912
2021-09-30 $9,585 1,921
2021-06-30 $12,152 1,864
2020-06-30 $998 200